William R. Larue's most recent trade in Oncternal Therapeutics Inc was a trade of 2,200 Stock Options done . Disclosure was reported to the exchange on June 20, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncternal Therapeutics Inc | William R. Larue | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 2,200 | 2,200 | - | - | Stock Options | |
| Oncternal Therapeutics Inc | William R. Larue | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 25,000 | 25,000 | - | - | Stock Options | |
| TRACON Pharmaceuticals Inc | William R. Larue | Director | Sale of securities on an exchange or to another person at price $ 1.26 per share. | 21 Dec 2022 | 120 | 7,763 (0%) | 0% | 1.3 | 151 | Common Stock |
| Oncternal Therapeutics Inc | William R. Larue | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 25,000 | 25,000 | - | - | Stock Options | |
| TRACON Pharmaceuticals Inc | William R. Larue | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 15,750 | 15,750 | - | - | Director Stock Option (Right to Buy) | |
| TRACON Pharmaceuticals Inc | William R. Larue | Director | Purchase of securities on an exchange or from another person at price $ 3.82 per share. | 26 Jul 2021 | 6,545 | 7,883 (0%) | 0% | 3.8 | 25,002 | Common Stock |
| TRACON Pharmaceuticals Inc | William R. Larue | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 10,500 | 10,500 | - | - | Director Stock Option (Right to Buy) | |
| Oncternal Therapeutics Inc | William R. Larue | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 25,000 | 25,000 | - | - | Stock Options |